Verzenio is available as a 50 mg, 100 mg, 150 mg, and 200 mg oral tablet with recommended dosing of 150 mg twice daily when given in combination with fulvestrant and 200 mg twice daily when given alone. The average wholesale price (AWP) per tablet is $234.60. NPS is planning to review Verzenio for placement on the national formularies. For additional details on Verzenio, please view the FDAâs press release.
TUESDAY, Oct. 20 (HealthDay News) -- New research raises doubts about the long-held medical dogma that dangerous blood clots in the lungs, known as pulmonary emboli, originate from clots in the deep veins of the legs or other parts of the lower body, which then break up and travel up through the body.
As a result of the broken bone, the bone marrow fat escapes into the bloodstream. Alternatively, fat embolism can also arise from with parenteral lipid infusion (a form of nutritional supplementation), pancreatitis, burns, childbirth, and other conditions.